GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediWound Ltd (NAS:MDWD) » Definitions » 5-Year Yield-on-Cost %

MDWD (MediWound) 5-Year Yield-on-Cost % : 0.00 (As of Mar. 25, 2025)


View and export this data going back to 2014. Start your Free Trial

What is MediWound 5-Year Yield-on-Cost %?

MediWound's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for MediWound's 5-Year Yield-on-Cost % or its related term are showing as below:



MDWD's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.59
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of MediWound's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, MediWound's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediWound's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MediWound's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where MediWound's 5-Year Yield-on-Cost % falls into.



MediWound 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of MediWound is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

MediWound  (NAS:MDWD) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


MediWound 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of MediWound's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


MediWound Business Description

Traded in Other Exchanges
Address
42 Hayarkon Street, Yavne, ISR, 8122745
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.